Stockreport

AgomAb Therapeutics NV Readies US IPO On Early Promising Results [Seeking Alpha]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF AGMB's IPO seeks $200 million at a $16.00/share midpoint, valuing the firm at a $497 million enterprise value - reasonable for a high-quality biotech. Early clinical [Read more]